Atlas Trials

Immune Checkpoint Receptors in AML-Leukemic Initiating Cells

Clinical trial NCT03449745 · COMPLETED

Trial details

NCT number
NCT03449745
Sponsor
University Hospital, Bordeaux
Status
COMPLETED
Study type
OBSERVATIONAL
Acute Myeloid Leukemia
Start date
2018-05-29
Primary completion
2021-06-09
Enrollment
199

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.